Drug Enforcement D-0540-2025

CGMP Deviations; potential temperature excursions due to transit delays

Status

Ongoing

Classification

Class II

Report Date

July 30, 2025

Termination Date

—

Product Information

Product description
BENLYSTA (belimumab) for injection, 400 mg/20 mL vial, Rx only, NDC 49401-102-01, GSK.
Product quantity
3 Vials
Reason for recall
CGMP Deviations; potential temperature excursions due to transit delays
Recall initiation reason
—
Initial firm notification
Letter
Distribution pattern
Within the U.S - OH, VA, FL.

Location & Firm

Recalling firm
Mckesson Medical-Surgical Inc. Corporate Office
Address
9954 Maryland Drive, Deep Run Iii Ste. 4000

United States
Voluntary / Mandated
Voluntary: Firm initiated
Status date
—

Codes & Dates

Recall number
D-0540-2025
Event ID
97110
Recall initiation date
April 21, 2025
Center classification date
July 21, 2025
Code info
Lot: YK4W, Expiration date: 4/30/2029
More code info
—